Zomedica Corp. Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain
Zomedica Corp. (ZOMDF) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain of $2.17 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain · last filed 2025-03-13
- Zomedica Corp. business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2023-12-31 was $0.00.
- Zomedica Corp. business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2023 was $2.17M.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $2.17M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $2.17M 10-Q · filed 2024-11-07 |